H.I.G. BioVentures Closes Second Fund Above Target, Team Upbeat
This article was originally published in The Pink Sheet Daily
Executive Summary
H.I.G. Capital announced the closing of BioVentures II, a diversified life science venture fund focusing on drugs, medical devices, and diagnostics.